Beta-carotene cuts dementia risk

Men who take beta-carotene supplements for 15 years or longer are less likely to develop dementia, according to US research.

Previous studies on the benefits of taking antioxidant supplements to fight dementia have been inconclusive.

US researchers studied the effects of beta-carotene on cognitive ability in two groups of men.

In 1982, 4,052 men were randomly assigned to take a placebo or beta-carotene, 50mg, every other day.

Between 1998-2001, an additional 1,904 men were randomly assigned to the groups, which were followed until 2003.

Men in the long-term group, but not the short term group, had significantly higher scores for several cognitive tests including verbal memory compared with men who took the placebo.

sanjay.tanday@haymarket.com

Comment below and tell us what you think

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register

Already registered?

Sign in

Follow Us:

Just published

Most children could be removed from shielded patient list, deputy CMO suggests

Most children could be removed from shielded patient list, deputy CMO suggests

Most children could be removed from the shielded patient list in a future wave of...

GPs can provide some care for shielded patients in clinical settings, NHS England confirms

GPs can provide some care for shielded patients in clinical settings, NHS England confirms

GPs can provide care to shielded patients in 'infection-controlled clinical settings'...

How digital assistants can help patients manage their health and wellbeing

How digital assistants can help patients manage their health and wellbeing

A project in Staffordshire has shown how practices can make use of digital technology...

Coronavirus: Key guidance GPs need to know about COVID-19

Coronavirus: Key guidance GPs need to know about COVID-19

GPonline provides an overview of the key guidance relating to coronavirus, including...

Fair death-in-service deal for locums vital before second COVID-19 wave, warns BMA

Fair death-in-service deal for locums vital before second COVID-19 wave, warns BMA

The government must do ‘the right thing’ and secure adequate death-in-service benefits...

GP workload fears over antibody testing rollout for 'no clinical benefit'

GP workload fears over antibody testing rollout for 'no clinical benefit'

GP practices are being contacted by patients asking for antibody tests as the government...